cladribine has been researched along with Polycythemia Vera in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT | 1 |
| Kasami, T; Katagiri, T; Kawamoto, K; Kobayashi, H; Masuko, M; Miyakoshi, S; Miyoshi, H; Nemoto, H; Ohshima, K; Shibasaki, Y; Sone, H; Suzuki, T; Takeuchi, K; Takizawa, J; Tamura, S | 1 |
2 other study(ies) available for cladribine and Polycythemia Vera
| Article | Year |
|---|---|
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia | 2018 |
Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
Topics: Aged; Amino Acid Substitution; Central Nervous System Diseases; Cladribine; Erdheim-Chester Disease; Humans; Janus Kinase 2; Male; Mutation, Missense; Polycythemia Vera; Proto-Oncogene Proteins B-raf | 2018 |